A Long-tem Efficacy, Safety, and Tolerability Study of BOTOX in Patients With Chronic Migraine
Phase of Trial: Phase IV
Latest Information Update: 27 Jun 2017
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Acronyms COMPEL
- Sponsors Allergan
- 27 Jun 2017 Results (n=442) of subanalysis assessing efficacy and safety in patients with baseline headache everyday or allodynia, presented at the 3rd Congress of the European Academy of Neurology.
- 27 Jun 2017 Results of subanalysis evaluating comorbid sleep disturbances and fatigue symptoms presented at the 3rd Congress of the European Academy of Neurology
- 11 Jun 2017 Results of subanalysis assessing effects of onabotulinumtoxinA prophylaxis on comorbid sleep disturbances and fatigue symptoms, presented at the 59th Annual Scientific Meeting of the American Headache Society.